Differentiation of osteoprogenitor cells is induced by high-frequency pulsed electromagnetic fields

Journal of Craniofacial Surgery

Volumn 23, Issue 2, 2012, Pages 586-593

  Teven, Chad M ^a   Greives, Matthew ^a   Natale, Ryan B ^a   Su, Yuxi ^a   Luo, Qing ^a   He, Bai Cheng ^a   Shenaq, Deana ^a   He, Tong Chuan ^a   Reid, Russell R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

High frequency pulsed electromagnetic fields; osteogenic differentiation; osteoprogenitor cell differentiation; pulsed electromagnetic fields

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 11, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN-ACTIVATED PROTEIN KINASE 11, MOUSE; OSTEOCALCIN; OSTEOPONTIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ELECTROMAGNETIC FIELD; ENZYME IMMUNOASSAY; METABOLISM; MOUSE; OSTEOBLAST; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKULL;

ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; ELECTROMAGNETIC FIELDS; IMMUNOENZYME TECHNIQUES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKULL;

EID: 84859179324     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31824cd6de     Document Type: Article

References (56)

1. Acarturk TO, Hollinger JO. Commercially available demineralized bone matrix compositions to regenerate calvarial critical-sized bone defects. Plast Reconstr Surg 2006;118:862-873 (Pubitemid 44412919)
2. Smartt JM Jr., Karmacharya J, Gannon FH, et al. Repair of the immature and mature craniofacial skeleton with a carbonated calcium phosphate cement: assessment of biocompatibility, osteoconductivity, and remodeling capacity. Plast Reconstr Surg 2005;115:1642-1650 (Pubitemid 40604734)
3. Gosain AK, Persing JA. Biomaterials in the face: benefits and risks. J Craniofac Surg 1999;10:404-414
4. Sargent LA, Fulks KD. Reconstruction of internal orbital fractures with vitallium mesh. Plast Reconstr Surg 1991;88:31-38
5. Hurvitz KA, Kobayashi M, Evans GR. Current options in head and neck reconstruction. Plast Reconstr Surg 2006;118:122e-133e (Pubitemid 44511397)
6. Chen L, Jiang W, Huang J, et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9Yinduced osteogenic differentiation and bone formation. J Bone Miner Res 2010;25:2447-2459
7. Luo J, Deng ZL, Luo X, et al. A protocol for rapid generation of recombinant adenoviruses using the adeasy system. Nat Protoc 2007;2:1236-1247 (Pubitemid 46908240)
8. Bassett CA, Pawluk RJ, Pilla AA. Acceleration of fracture repair by electromagnetic fields. A surgically noninvasive method. Ann N Y Acad Sci 1974;238:242-262
9. Griffin XL, Warner F, Costa M. The role of electromagnetic stimulation in the management of established non-union of long bone fractures: what is the evidence? Injury 2008;39:419-429
10. Aaron RK, Ciombor DM, Simon BJ. Treatment of nonunions with electric and electromagnetic fields. Clin Orthop Relat Res 2004;419:21-29 (Pubitemid 38269666)
11. Deibert MC, McLeod BR, Smith SD, et al. Ion resonance electromagnetic field stimulation of fracture healing in rabbits with a fibular ostectomy. J Orthop Res 1994;12:878-885 (Pubitemid 24377738)
12. Rubin CT, Donahue HJ, Rubin JE, et al. Optimization of electric field parameters for the control of bone remodeling: exploitation of an indigenous mechanism for the prevention of osteopenia. J Bone Miner Res 1993;8(suppl 2):S573YS581
13. Tabrah F, Hoffmeier M, Gilbert F Jr., et al. Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs). J Bone Miner Res 1990;5:437-442 (Pubitemid 20204501)
14. Kucharzyk DW. A controlled prospective outcome study of implantable electrical stimulation with spinal instrumentation in a high-risk spinal fusion population. Spine (Phila, Pa 1976) 1999;24:465-468; discussion 469
15. Bodamyali T, Bhatt B, Hughes FJ, et al. Pulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro. Biochem Biophys Res Commun 1998;250:458-461 (Pubitemid 28463900)
16. Schwartz Z, Simon BJ, Duran MA, et al. Pulsed electromagnetic fields enhance BMP-2 dependent osteoblastic differentiation of human mesenchymal stem cells. J Orthop Res 2008;26:1250-1255
17. Selvamurugan N, Kwok S, Vasilov A, et al. Effects of BMP-2 and pulsed electromagnetic field (PEMF) on rat primary osteoblastic cell proliferation and gene expression. J Orthop Res 2007;25:1213-1220 (Pubitemid 47365295)
18. Lohmann CH, Schwartz Z, Liu Y, et al. Pulsed electromagnetic field stimulation of mg63 osteoblast-like cells affects differentiation and local factor production. J Orthop Res 2000;18:637-646
19. Kinney BM. Pulsed electromagnetic field therapy in plastic surgery. Aesthet Surg J 2005;25:87-91 (Pubitemid 40277210)
20. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-1552 (Pubitemid 36951140)
21. Luo X, Sharff KA, Chen J, et al. S100a6 expression and function in human osteosarcoma. Clin Orthop Relat Res 2008;466: 2060-2070
22. Tang N, Song WX, Luo J, et al. BMP-9Yinduced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med 2009;13:2448-2464
23. Westerman KA, Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci U S A 1996;93:8971-8976 (Pubitemid 26282002)
24. Sharff KA, Song WX, Luo X, et al. He-1 basic helix-loop-helix protein plays an important role in mediating BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 2009;284:649-659
25. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004;11:1312-1320 (Pubitemid 39213996)
26. Peng Y, Kang Q, Cheng H, et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)Ymediated osteogenic signaling. J Cell Biochem 2003;90:1149-1165 (Pubitemid 37485051)
27. Peng Y, Kang Q, Luo Q, et al. Inhibitor of DNA binding/ differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004;279:32941-32949 (Pubitemid 39014754)
28. Luo Q, Kang Q, Si W, et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004;279:55958-55968 (Pubitemid 40066603)
29. Si W, Kang Q, Luu HH, et al. CCN1/CYR61 is regulated by the canonical Wnt signal and plays an important role in Wnt3a-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006;26:2955-2964
30. Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009;18:545-559
31. Bi Y, Huang J, He Y, et al. Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 2009;108:295-303
32. Zhu GH, Huang J, Bi Y, et al. Activation of RXR and rar signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 2009;78:195-204
33. He BC, Gao JL, Zhang BQ, et al. Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 2011;79:211-219
34. Haydon RC, Zhou L, Feng T, et al. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 2002;8:1288-1294 (Pubitemid 34517670)
35. He BC, Chen L, Zuo GW, et al. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res 2010;16:2235-2245
36. Su Y, Luo X, He BC, et al. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis 2009;26:599-610
37. Ishiyama M, Tominaga H, Shiga M, et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996;19:1518-1520 (Pubitemid 26403266)
38. Jansen JH, van der Jagt OP, Punt BJ, et al. Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study. BMC Musculoskelet Disord 2010;11:188
39. Tsai MT, Chang WH, Chang K, et al. Pulsed electromagnetic fields affect osteoblast proliferation and differentiation in bone tissue engineering. Bioelectromagnetics 2007;28:519-528 (Pubitemid 47556772)
40. Xiao G, Gopalakrishnan R, Jiang D, et al. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17:101-110 (Pubitemid 33151001)
41. Lai CF, Chaudhary L, Fausto A, et al. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001;276:14443-14450
42. Jaiswal RK, Jaiswal N, Bruder SP, et al. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 2000;275:9645-9652 (Pubitemid 30185197)
43. Zarubin T, Han J. Activation and signaling of the p38 map kinase pathway. Cell Res 2005;15:11-18 (Pubitemid 41653958)
44. Kumar S, Boehm J, Lee JC. P38 map kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003;2:717-726 (Pubitemid 37361787)
45. Luu HH, Song WX, Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 2007;25:665-677 (Pubitemid 46730519)
46. He TC. Distinct osteogenic activity of BMPs and their orthopaedic applications. J Musculoskelet Neuronal Interact 2005;5:363-366
47. Tessier P, Kawamoto H, Matthews D, et al. Autogenous bone grafts and bone substitutesYtools and techniques: I. A 20,000-case experience in maxillofacial and craniofacial surgery. Plast Reconstr Surg 2005;116:6S-24S; discussion 92S-94S (Pubitemid 41446788)
48. Neovius E, Engstrand T. Craniofacial reconstruction with bone and biomaterials: reviewover the last 11 years. J Plast Reconstr Aesthet Surg 2010;63:1615-1623
49. Gosain AK, Chim H, Arneja JS. Application-specific selection of biomaterials for pediatric craniofacial reconstruction: developing a rational approach to guide clinical use. Plast Reconstr Surg 2009;123:319-330
50. Chim H, Gosain AK. Biomaterials in craniofacial surgery: experimental studies and clinical application. J Craniofac Surg 2009;20:29-33
51. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol 2005;94:1-22 (Pubitemid 44608653)
52. Teven CM, Liu X, Hu N, et al. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adiopogenic differentiation. Stem Cells Int 2011;2011:201371
53. Vecchia P, Matthes R, Ziegelberger G, et al. Exposure to High Frequency Electromagnetic Fields, Biological Effects and Health Consequences (100 kHz-300 GHz). Germany Munich: International Commission on Non-ionizing Radiation Protection; 2009;16:1-392
54. Balcavage WX, Alvager T, Swez J, et al. A mechanism for action of extremely low frequency electromagnetic fields on biological systems. Biochem Biophys Res Commun 1996;222:374-378 (Pubitemid 26335023)
55. Hu Y, Chan E, Wang SX, et al. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 2003;144:2068-2074 (Pubitemid 36543347)
56. Noth U, Tuli R, Seghatoleslami R, et al. Activation of p38 and smads mediates BMP-2 effects on human trabecular boneYderived osteoblasts. Exp Cell Res 2003;291:201-211 (Pubitemid 37338693)